189 related articles for article (PubMed ID: 22305281)
21. Adherence to topical dermatological therapy: lessons from oral drug treatment.
Gupta G; Mallefet P; Kress DW; Sergeant A
Br J Dermatol; 2009 Aug; 161(2):221-7. PubMed ID: 19548959
[TBL] [Abstract][Full Text] [Related]
22. Topical therapy for psoriasis.
Lebwohl M; Abel E; Zanolli M; Koo J; Drake L
Int J Dermatol; 1995 Oct; 34(10):673-84. PubMed ID: 8537153
[No Abstract] [Full Text] [Related]
23. Adherence to topical therapy increases around the time of office visits.
Feldman SR; Camacho FT; Krejci-Manwaring J; Carroll CL; Balkrishnan R
J Am Acad Dermatol; 2007 Jul; 57(1):81-3. PubMed ID: 17498841
[TBL] [Abstract][Full Text] [Related]
24. Self-medication and adherence to treatment in psoriasis.
Kivelevitch DN; Tahhan PV; Bourren P; Kogan NN; Gusis SE; Rodríguez EA
Int J Dermatol; 2012 Apr; 51(4):416-9. PubMed ID: 22435429
[TBL] [Abstract][Full Text] [Related]
25. Topical calcipotriene 0.005% and betamethasone dipropionate 0.064% maintains efficacy of etanercept after step-down dose in patients with moderate-to-severe plaque psoriasis: results of an open label trial.
Kircik LH
J Drugs Dermatol; 2011 Aug; 10(8):878-82. PubMed ID: 21818509
[TBL] [Abstract][Full Text] [Related]
26. Quality of care in patients with psoriasis: an initial clinical study of an international disease management programme.
de Korte J; Van Onselen J; Kownacki S; Sprangers MA; Bos JD
J Eur Acad Dermatol Venereol; 2005 Jan; 19(1):35-41. PubMed ID: 15649189
[TBL] [Abstract][Full Text] [Related]
27. Determining the relative importance of patient motivations for nonadherence to topical corticosteroid therapy in psoriasis.
Brown KK; Rehmus WE; Kimball AB
J Am Acad Dermatol; 2006 Oct; 55(4):607-13. PubMed ID: 17010739
[TBL] [Abstract][Full Text] [Related]
28. [Ambulatory treatment of psoriasis with psoil].
Schöldgen W
Asthet Med (Berl); 1967 Sep; 16(9):275-80. PubMed ID: 5303359
[No Abstract] [Full Text] [Related]
29. Canadian Patients' Preferences in Topical Psoriasis Care: Insights From the PROPEL Surveys.
Vender R; Gooderham MJ; Guenther LC; Kyritsis D; Rao J; Kowalczyk A; Ashkenas J
J Cutan Med Surg; 2018; 22(5):464-471. PubMed ID: 29754528
[TBL] [Abstract][Full Text] [Related]
30. Drug supply for psoriasis - results from a national pharmacy network.
Franzke N; Montenbruck M; Langenbruch AK; Beikert FC; Kresken J; Augustin M
J Dtsch Dermatol Ges; 2013 Jul; 11(7):638-43. PubMed ID: 23464851
[TBL] [Abstract][Full Text] [Related]
31. Topical application of calcipotriene and corticosteroids: combination regimens.
Lebwohl M
J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S55-8. PubMed ID: 9344186
[TBL] [Abstract][Full Text] [Related]
32. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: quality-of-life outcomes of a randomized controlled trial of supervised treatment of psoriasis in a day-care setting.
de Korte J; van der Valk PG; Sprangers MA; Damstra RJ; Kunkeler AC; Lijnen RL; Oranje AP; de Rie MA; de Waard-van der Spek FB; Hol CW; van de Kerkhof PC
Br J Dermatol; 2008 Feb; 158(2):375-81. PubMed ID: 18067483
[TBL] [Abstract][Full Text] [Related]
33. Calcipotriol plus betamethasone dipropionate gel compared with its active components in the same vehicle and the vehicle alone in the treatment of psoriasis vulgaris: a randomised, parallel group, double-blind, exploratory study.
Fleming C; Ganslandt C; Guenther L; Johannesson A; Buckley C; Simon JC; Stegmann H; Vestergaard Tingleff L
Eur J Dermatol; 2010; 20(4):465-71. PubMed ID: 20413372
[TBL] [Abstract][Full Text] [Related]
34. What is new in topical therapy for psoriasis?
Reich K; Bewley A
J Eur Acad Dermatol Venereol; 2011 Jun; 25 Suppl 4():15-20. PubMed ID: 21507079
[TBL] [Abstract][Full Text] [Related]
35. Increasing use of non-traditional vehicles for psoriasis and other inflammatory skin conditions.
Huang KE; Davis SA; Cantrell J; Feldman SR
Dermatol Online J; 2014 Sep; 20(9):. PubMed ID: 25244174
[TBL] [Abstract][Full Text] [Related]
36. Clobetasol propionate followed by calcipotriol is superior to calcipotriol alone in topical treatment of psoriasis.
Austad J; Bjerke JR; Gjertsen BT; Helland S; Livden JK; Morken T; Mørk NJ
J Eur Acad Dermatol Venereol; 1998 Jul; 11(1):19-24. PubMed ID: 9731961
[TBL] [Abstract][Full Text] [Related]
37. Effective treatment and improvement of quality of life in patients with scalp psoriasis by topical use of calcipotriol/betamethasone (Xamiol®-gel): results.
Mrowietz U; Macheleidt O; Eicke C
J Dtsch Dermatol Ges; 2011 Oct; 9(10):825-31. PubMed ID: 21564540
[TBL] [Abstract][Full Text] [Related]
38. Comparing clobetasol propionate 0.05% spray to calcipotriene 0.005% betamethasone dipropionate 0.064% ointment for the treatment of moderate to severe plaque psoriasis.
Menter A; Abramovits W; Colón LE; Johnson LA; Gottschalk RW
J Drugs Dermatol; 2009 Jan; 8(1):52-7. PubMed ID: 19180896
[TBL] [Abstract][Full Text] [Related]
39. Pimecrolimus 1 percent cream in the treatment of psoriasis in a child.
Mansouri P; Farshi S
Dermatol Online J; 2006 Feb; 12(2):7. PubMed ID: 16638400
[TBL] [Abstract][Full Text] [Related]
40. Topical delivery for the treatment of psoriasis.
Mitra A; Wu Y
Expert Opin Drug Deliv; 2010 Aug; 7(8):977-92. PubMed ID: 20645673
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
